alexa
Reach Us +1-947-333-4405
Evaluation Of Osteopontin In Combination With Other Bone Turnover Markers For The Assesment Of Osteoporosis In Menopausal Women | 9233
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference and Exhibition on Pathology

Sara Reza
Accepted Abstracts: J Clin Exp Pathol
DOI: 10.4172/2161-0681.S1.010
Abstract
Introduction: Osteoporosis, a disease characterized by low bone mass and microarchitectural deterioration of bone tissue, has an important impact on the lives of postmenopausal women, owing to the increased risk of fractures. Although bone mineral density (BMD) is the most common tool used to assess fracture risk in these patients, a significant change in BMD usually requires more than a year to take place, without any role in therapy monitoring. Biochemical markers of bone turnover are early indicators of bone loss, fracture risk and intervention threshold. Osteopontin, a glycoprotein has been implicated in bone remodeling by activating the resorption process. Combination of osteopontin with classical bone turnover markers can enhance the confidence of predicting fracture risk and outcome of therapy. Methods: Enzyme-linked immunosorbent assay technique was used to measure serum osteopontin, osteocalcin, bone alkaline phosphatase (bALP), collagen type 1 cross linked telopeptide (CTX) and urinary hydroxyproline. Results: Osteopontin was positively correlated with osteocalcin (r=0.82), bALP (r=0.76), CTX (r=0.62) and hydroxyproline (r=0.49) and it was negatively correlated with BMD (r=-0.71) indicating significant correlation (p<0.001). The osteopontin and osteocalcin combination showed highest sensitivity and specificity. 6 months after antiresorptive therapy 40-60% fall was observed in the level of these bone turnover markers while there was no statistically significant change in BMD. Conclusion: High levels of osteopontin in postmenopausal women are associated with low BMD, increased levels of bone turnover markers, and fractures. When used in combination with other bone turnover markers, it can provide an effective assessment of fracture risk and warrants role in monitoring of therapy.
Biography
Sara Reza has completed her degree of medicine in 2009 with a number of awards and distinctions. She worked as a house officer in general medicine and surgery for one year. After which she passed her Fellowship of College of Physicians and Surgeons (FCPS) part one examination and commenced her training for the four year program in discipline of chemical pathology. Currently she is third year resident at Quaid-e-Azam Medical College, Pakistan. She is also working as Incharge Chemical Pathology laboratory at the same institute catering 1800 bedded hospital, Bahawal Victoria Hospital, Pakistan. Sara is also serving as the assistant editor of newsletter ?THE SPECTRUM? of Pakistan Society of Chemical Pathologists (PSCP). She has participated in various conferences and recently her two research articles have been published in reputed journals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2019-20
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljo[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

ankara escort

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

pendik escort

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2019 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version